Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
I-MAB (IMAB)
NASDAQ:IMAB
I-MAB (IMAB) Stock Price & Analysis
126 Followers
IMAB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.73 - $12.76
Previous Close$3.14
Volume174.75K
Average Volume (3M)344.99K
Market Cap
$258.34M
Enterprise Value-$3.08B
Total Cash (Recent Filing)¥3.34B
Total Debt (Recent Filing)¥10.87M
Price to Earnings (P/E)-0.7
Beta1.07
Next Earnings
Aug 29, 2023EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.46
Shares Outstanding83,440,000
10 Day Avg. Volume196,878
30 Day Avg. Volume344,992
Standard Deviation0.23
R-Squared0.06
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.10
Price to Sales (P/S)-1.18
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$25.00Price Target Upside696.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
I-MAB News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMAB FAQ
What was I-MAB’s price range in the past 12 months?
I-MAB lowest stock price was $2.73 and its highest was $12.76 in the past 12 months.
What is I-MAB’s market cap?
Currently, no data Available
When is I-MAB’s upcoming earnings report date?
I-MAB’s upcoming earnings report date is Aug 29, 2023 which is in 80 days.
How were I-MAB’s earnings last quarter?
I-MAB released its earnings results on Mar 31, 2023. The company reported -$0.14 earnings per share for the quarter, the consensus estimate of -$0.14 by $0.
Is I-MAB overvalued?
According to Wall Street analysts I-MAB’s price is currently Undervalued.
Does I-MAB pay dividends?
I-MAB does not currently pay dividends.
What is I-MAB’s EPS estimate?
I-MAB’s EPS estimate is -$0.34.
How many shares outstanding does I-MAB have?
I-MAB has 83,439,740 shares outstanding.
What happened to I-MAB’s price movement after its last earnings report?
I-MAB reported an EPS of -$0.14 in its last earnings report, expectations of -$0.14. Following the earnings report the stock price went down -1.705%.
Which hedge fund is a major shareholder of I-MAB?
Among the largest hedge funds holding I-MAB’s share is Bridgewater Associates, LP. It holds I-MAB’s shares valued at 524K.
---
I-MAB Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
I-MAB
I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
---
Top 5 ETFs holding IMAB
iShares NASDAQ US Biotechnology UCITS ETF
$104.60K
Invesco Nasdaq Biotechnology ETF
$4.07K
Up to five ETFs with an Outperform Smart Score that hold IMAB. The ETFs are listed according to market value of IMAB within the ETF
---
RAPT Therapeutics
―
Bellicum Pharmaceuticals
―
Takeda Pharmaceutical Company
―
Rocket Pharmaceuticals
―
---